Apathy and executive cognitive dysfunction (ECD) are important though conceptually different aspects of late-life depression. The primary objective of this study was to evaluate the relationship of apathy to ECD. The authors also evaluated the relationship of apathy and ECD to global cognitive impairment and word generation. Fifty-two elderly subjects with major depression and MMSE scores of 15 or greater were evaluated with apathy-related items from the Hamilton rating scale for depression (ApHRSD), the Executive Interview (EXIT), the Dementia Rating Scale (DRS), and the Controlled Oral Word Association test (COWA). ApHRSD scores were not significantly correlated with any of these variables. EXIT scores were correlated significantly with DRS and COWA. The results suggest that apathy and ECD may be independent of each other in some samples of elderly with late-life depression. Correlations may have been reduced by low variance for the variables of interest and by psychometric limitations of the ApHRSD. (J Geriatr Psychiatry Neurol 2003; 16:112-116)
Get full access to this article
View all access options for this article.
References
1.
1. Krishnan K, Ranga R, Hays JC, et al. Clinical and phenomenological comparisons of late-onset and early-onset depression. Am J Psychiatry1995; 152:785-788.
2.
2. Cassens G, Wolfe L, Zola M. Neuropsychology of depression. J Neuropsychiatry Clin Neurosci1990; 2:202-213.
3.
3. Royall DR. Frontal systems impairment in major depression. Semin Clin Neuropsychiatry1999; 4(1):13-23.
4.
4. Alexopoulos GS, Meyers BS, Young RC, et al. Executive dysfunction and long-term outcomes of geriatric depression. Arch Gen Psychiatry2000; 57:285-290.
5.
5. Marin RS, Firincigullari S, Biedrzycki RC. Reliability and validity of the Apathy Evaluation Scale. Psychiatry Res1991; 38:143-162.
6.
6. Lezak M. Neuropsychological assessment. New York: Oxford University Press, 1995.
7.
7. Royall DR, Mahurin RK, Gray K. Bedside assessment of executive cognitive impairment: The Executive Interview (EXIT). J Am Geriatr Soc1992; 40:1221-1226.
8.
8. Stuss D, Van Reekum R. Apathy. In: Borod JC, ed. The neuropsychology of emotion. New York: Oxford University Press, 2000.
9.
9. Marin RS, Biedrzycki RC, Firinciogullari S. The sources of convergence between measures of apathy and depression. J Affect Disord1993; 28:117-124.
10.
10. Levy ML, Cummings L, Fairbanks LA, et al. Apathy is not depression. J Neuropsychiatry Clin Neurosci1998; 10:314-319.
11.
11. Starkstein SE, Mayberg HS, Preziosi TJ, et al. Reliability, validity, and clinical correlates of apathy in Parkinson's disease. J Neuropsychiatry Clin Neurosci1992; 4:134-139.
12.
12. Castellon SA, Hinkin CH, Wood S, Yarema KT. Apathy, depression, and cognitive performance in HIV-1 infection. J Neuropsychiatry Clin Neurosci1998; 10(3):320-329.
13.
13. Kuzis G, Sabe L, Tiberti C, et al. Neuropsychological correlates of apathy and depression in patients with dementia. Neurology1999; 52(7):1403-1407.
14.
14. Alexopoulos GS, Meyers BS, Young RC, et al. Executive dysfunction and long-term outcomes of geriatric depression. Arch Gen Psychiatry2000; 57(3):285-290.
15.
15. Kiosses DN, Alexopoulos GS, Murphy C. Symptoms of striatofrontal dysfunction contribute to disability in geriatric depression. Int J Geriatr Psychiatry2000; 15(11):992-999.
16.
16. Kiosses DN, Klimstra S, Murphy C, Alexopoulos GS. Executive dysfunction and disability in elderly patients with major depression. Am J Geriatr Psychiatry2001; 9(3):269-274.
17.
17. Schmidt R, Fazekas F, Kapeller P, et al. MRI white matter hyperintensities: three-year follow-up of the Austrian Stroke Prevention Study. Neurology1999; 53(1):132-139.
18.
18. Fazekas F, Schmidt R, Kleinert R, et al. The spectrum of age-associated brain abnormalities: their measurement and histopathological correlates. J Neural Transm Suppl1998; 53:31-39.
23. Alexopoulos GS. “The depression-executive dysfunction syndrome of late life”: a specific target for D3 agonists? Am J Geriatr Psychiatry2001; 9(1):22-29.
24.
24. Mega MS, Cummings JL. Frontal-subcortical circuits and neuropsychiatric disorders. J Neuropsychiatry Clin Neurosci1994; 6(4):358-370.
25.
25. Mulsant BH, Pollock BG, Nebes R, et al. A 12-week double-blind randomized comparison of nortriptyline and paroxetine in older depressed inpatients and outpatients. Am J Geriatr Psychiatry2001; 9:406-414.
26.
26. First MB, Spitzer RL, Gibbon M, Williams JBW. Structured Clinical Interview of Axis-I DSM-IV Disorders-Patient Edition (SCID-I/P, version 2.0). New York: Biometric Research Department, New York State Psychiatric Institute, 1994.
27.
27. Miller MD, Paradis CF, Houck PR, et al. Rating chronic medical illness burden in geropsychiatric practice and research: application of the Cumulative Illness Rating Scale. Psychiatry Res1992; 41(3):237-248.
28.
28. Marin RS. The Apathy Evaluation Scale. In: Handbook of psychiatric measurements. Washington, DC: American Psychiatric Association, 2000.
32. Borkowski JG, Benton AL, Spreen O. Word fluency and brain damage. Neuropsychologia1967; 5:135-140.
33.
33. Craig AH, Cummings JL, Fairbanks L, et al. Cerebral blood flow correlates of apathy in Alzheimer disease. Arch Neurol1996; 53(11):1116-1120.
34.
34. Schneider LS, Reynolds CF, Lebowitz BD, et al. Diagnosis and treatment of depression in late life: results of the NIH Consensus Development Conference. Washington, DC: American Psychiatric Press, 1994.
35.
35. Marin RS. Apathy and related disorders of diminished motivation. In: LJ Dickstein, MB Riba, JM Oldham, eds. Review of psychiatry, vol 15. Washington, DC: American Psychiatric Press, 1996:205-242.
36.
36. Fogel BS. The significance of frontal system disorders for medical practice and health policy. J Neuropsychiatry Clin Neurosci1994; 6(4):343-347.
37.
37. Daffner KR, Mesulam MM, Cohen LG. Mechanisms underlying diminished novelty-seeking behavior in patients with probable Alzheimer's disease. Neurocase1999; 12:58-66.
